The treatment of malignant mesothelioma with a gene modified cancer cell line: a phase I study.
Schwarzenberger P, Harrison L, Weinacker A, Marrogi A, Byrne P, Ramesh R, Theodossiou C, Gaumer R, Summer W, Freeman SM, Kolls JK.
Schwarzenberger P, et al. Among authors: kolls jk.
Hum Gene Ther. 1998 Nov 20;9(17):2641-9. doi: 10.1089/hum.1998.9.17-2641.
Hum Gene Ther. 1998.
PMID: 9853530
Clinical Trial.